Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 billion
Novonesis said on Tuesday that it had agreed to buy the stake of its partner, Swiss-Dutch chemical manufacturer DSM-Firmenich, in their joint enzymes venture for 1.5 billion euros ($1.55 billion). The ...
Novonesis: Still Too Expensive
Novonesis is a strong business with stable margins and high ROIC, but recent growth rates have declined. See why NVZMF stock ...
Novonesis (Novozymes A/S): Novonesis to acquire dsm-firmenich's share of the Feed Enzyme Alliance
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 ...
Hosted on MSN11mon
Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
Is Novozymes A/S (NVZMY) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Basic Materials peers, we might be able to answer that question.
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 ...